Medscape news story
Post-exposure prophylaxis-in-pocket (PIP) was associated with healthcare savings and improved quality of life outcomes compared to PrEP, based on data presented at CROI 2026.
Although daily PrEP is effective for HIV prevention, treatment gaps remain for individuals reluctant to start PrEP, or those whose infrequent exposures (defined as one to four per year) make them less than ideal candidates for PrEP.
PIP offers an alternative strategy in the form of a 28-day course of HIV medication for low-risk individuals to keep at home and initiate if needed. PIP is now endorsed by the World Health Organization and allows individuals to start treatment themselves within 72 hours of exposure, eliminating the need for an emergency department or clinic visit. However, real-world data comparing PIP to standard PrEP are lacking.
Read the full news story here.
/free registration is required/
View all Medscape reports from CROI 2026
Source : Medscape
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.